Digital Diagnostics Global Market Report 2025

Digital diagnostics refers to the use of advanced digital technologies, including artificial intelligence (AI), machine learning, data analytics, and imaging systems, to identify, monitor, and predict health conditions with high precision and efficiency. By utilizing electronic health records (EHRs), wearable devices, and diagnostic tools, real-time data collection, analysis, and interpretation can assist healthcare professionals in making accurate medical decisions.

The main products in digital diagnostics include hardware, software, and services. Hardware refers to the physical devices used for conducting tests and collecting health data. These technologies are applied in various fields, such as cardiology, gynecology, infectious diseases, oncology, diabetes, and more. They are used by hospitals, clinics, clinical laboratories, pharmaceutical and biotechnology companies, academic and research institutions, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The digital diagnostics market research report is one of a series of new reports from The Business Research Company that provides digital diagnostics market statistics, including digital diagnostics industry global market size, regional shares, competitors with a digital diagnostics market share, detailed digital diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the digital diagnostics industry. This digital diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital diagnostics market size has grown exponentially in recent years. It will grow from $1.76 billion in 2024 to $2.15 billion in 2025 at a compound annual growth rate (CAGR) of 22.4%. The growth in the historic period can be attributed to increasing investment and funding, increasing awareness and training, increasing funding for R&D, increasing emphasis on ESG factors and increasing patient-centric approaches.

The digital diagnostics market size is expected to see exponential growth in the next few years. It will grow to $4.8 billion in 2029 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to global health initiatives, globalization of healthcare, cultural shift towards digital solutions, support from healthcare institutions, and expansion of diagnostic capabilities. Major trends in the forecast period include expansion of point-of-care testing, growth of telemedicine solutions, development of advanced software solutions, expansion of digital pathology solutions, and block chain for data security.

The forecast of 22.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. healthcare providers by driving up the cost of Artificial intelligence(AI)-powered diagnostic imaging software and portable ultrasound devices sourced from China and Sweden, exacerbating hospital capital expenditures and delaying point-of-care testing adoption. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic illnesses is expected to fuel the growth of the digital diagnostics market. This increase can be attributed to factors such as aging populations, growing obesity rates, sedentary lifestyles, environmental influences, and improved awareness and diagnosis of these conditions. Digital diagnostics play a crucial role in managing chronic illnesses by enabling continuous monitoring, early detection of complications, and personalized treatment adjustments, all of which contribute to better long-term disease management and patient outcomes. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported approximately 20 million new cancer cases and 9.7 million cancer-related deaths in 2022. Lung cancer, with 2.5 million new cases (12.4% of all new cases), was the most common type, followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million cases, 7.3%), and stomach cancer (970,000 cases, 4.9%). The WHO also projected that countries with high Human Development Index (HDI) would experience the most significant increase in cancer incidence, with an additional 4.8 million new cases expected by 2050 compared to 2022. Consequently, the growing number of chronic illness cases is driving the expansion of the digital diagnostics market.

Major players in the digital diagnostics market are increasingly focusing on creating advanced products such as digital cytology systems to improve diagnostic precision, streamline processes, and enable remote analysis using advanced imaging and AI-based tools. A digital cytology system is an innovative diagnostic platform that leverages imaging technology and artificial intelligence to assess and interpret cytological samples, ensuring more accurate and efficient diagnoses. For example, in February 2024, Hologic Inc., a medical technology company based in the United States, received approval from the U.S. Food and Drug Administration (FDA) for its Genius Digital Diagnostics System, which includes the Genius Cervical AI algorithm. This system is the first FDA-cleared digital cytology platform that combines deep-learning AI with advanced volumetric imaging to detect pre-cancerous lesions and cervical cancer cells. Unlike conventional methods, where cervical cells from a Pap test are examined manually under a microscope, the Genius system digitizes the slides and uses AI to highlight important cells, which cytologists and pathologists can then review.

In October 2023, Kingsway Financial Services, a holding company based in the United States, acquired Digital Diagnostics Imaging for $11 million. This acquisition allows Kingsway Financial Services to strengthen its healthcare portfolio by incorporating Digital Diagnostics Imaging's remote cardiac monitoring services. The addition of these services is expected to generate recurring revenue and broaden Kingsway's presence in the expanding telehealth market. Digital Diagnostics Imaging is a US-based company that specializes in providing digital diagnostic systems and services.

Major players in the digital diagnostics market are Hoffmann-La Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Koninklijke Philips N.V., General Electric Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., Fulgent Genetics Inc., Guardant Health Inc., Tempus Labs Inc., Genomic Health Inc., EDX Medical Inc., PathAI Inc., Healthy.io Ltd., BrightInsight Inc., Digital Diagnostics Inc., Brainomix Limited, DnaNudge Ltd., and GRAIL Inc.

North America was the largest region in the digital diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital diagnostics market consists of revenues earned by entities by providing services such as remote patient monitoring, digital imaging analysis, telehealth diagnostics, and genomic and biomarker analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital diagnostics market also includes sales of digital X-ray systems, point-of-care testing devices, pathology slide scanners, and genetic testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Hardware; Software; Services
• 2) By Application: Cardiology; Gynecology; Infectious Diseases; Oncology; Diabetes; Other Applications
• 3) By End-Users: Hospitals And Clinics; Clinical Laboratories; Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
• Subsegments:

1 By Hardware: Diagnostic Devices; Wearable Devices; Sensors And Monitoring Equipment

• 2) By Software: Diagnostic Software; Data Analytics Software; Artificial Intelligence (AI) And Machine Learning Software; Cloud-Based Platforms
• 3) By Services: Diagnostic Testing Services; Telemedicine And Remote Monitoring Services; Data Management And Analytics Services
• Companies Mentioned: Hoffmann-La Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers ; Koninklijke Philips N.V.; General Electric Company; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Hologic Inc.; bioMerieux S.A.; Bio-Rad Laboratories Inc.; Fulgent Genetics Inc.; Guardant Health Inc.; Tempus Labs Inc.; Genomic Health Inc.; EDX Medical Inc.; PathAI Inc.; Healthy.io Ltd.; BrightInsight Inc.; Digital Diagnostics Inc.; Brainomix Limited; DnaNudge Ltd.; GRAIL Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.